Home/Filings/4/0001493152-23-007304
4//SEC Filing

Howe Jill Ann 4

Accession 0001493152-23-007304

CIK 0000876343other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 7:02 PM ET

Size

5.5 KB

Accession

0001493152-23-007304

Insider Transaction Report

Form 4
Period: 2023-03-09
Howe Jill Ann
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-09+150,000150,000 total
    Exercise: $1.46Exp: 2033-03-09Common Shares (150,000 underlying)
Footnotes (1)
  • [F1]One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

Documents

1 file

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1
  • filerCIK 0001892397

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:02 PM ET
Size
5.5 KB